| Pharmaceutical active ingredients: |
| Clorazepate Dipotassium |
| Available forms, composition and doses of Tranxene-SD: |
| Tablets; Oral; Clorazepate Dipotassium 11.25 mgTablets; Oral; Clorazepate Dipotassium 22.5 mg |
| Tranxene-SD medical category: |
| Human:Benzodiazepines |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05BA05 - Potassium Clorazepate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisLundbeckOvation Pharmaceuticals |
| Related documents and information about Tranxene-SD: |
| Tranxene T-Tab prescribing information (PDF) |